Keyphrases
1918 Influenza Pandemic
7%
Adverse Events
7%
Affinity Analysis
7%
Anti-influenza
100%
Antibody Affinity
7%
Argentina
7%
Australia
7%
Breastfeeding Women
7%
Clinical Benefit
14%
Clinical Site
7%
Clinical Status
7%
Common Odds Ratio
7%
Convalescent Plasma
7%
Denmark
7%
Greece
7%
Hazard Ratio
7%
Health Risk
7%
Hemagglutination Inhibition
14%
Hospital Treatment
7%
Hyperimmune Serum
100%
Influenza A
100%
Influenza B
100%
Influenza Season
7%
Influenza-like Illness
14%
Intravenous Immunoglobulin (IVIg)
100%
Intravenous Immunoglobulin Therapy
7%
Laboratory-confirmed Influenza
7%
Medical Research Council
7%
Mexico
7%
National Early Warning Score
7%
National Research Foundation
7%
NIAID
7%
Nonrandomized Studies
7%
Normal Activity
7%
Odds Ratio
21%
Opposite Effects
7%
Ordinal Outcome
7%
Oseltamivir
7%
Partial Support
7%
Permuted Block Randomization
7%
Pharmacist
7%
Placebo
14%
Placebo Groups
42%
Pregnant Women
7%
Proportional Odds Model
14%
Randomized Controlled Trial
7%
Randomized Placebo-controlled Trial
100%
Safety Outcomes
7%
Serious Adverse Events
7%
Small Clinical Trials
7%
Spain
7%
Subgroup Analysis
7%
Thailand
7%
Titre
28%
Treatment Assignment
7%
Web Application
7%
Medicine and Dentistry
Adverse Event
14%
Antibody Affinity
7%
Hazard Ratio
7%
Health Hazard
7%
Hemagglutination Inhibition
14%
Immunoglobulin
100%
Infection
100%
Influenza
14%
Influenza A
100%
Influenza B
100%
Infusion
28%
Medical Research
7%
Odds Ratio
28%
Oseltamivir
7%
Placebo
100%
Randomized Controlled Trial
7%
Small Clinical Trial
7%
Spanish Influenza
7%
Subgroup Analysis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
14%
Health Hazard
7%
Immunoglobulin
100%
Infection
100%
Influenza
14%
Influenza A
100%
Influenza B
100%
Oseltamivir
7%
Placebo
100%
Randomized Controlled Trial
7%
Small Clinical Trial
7%
Spanish Influenza
7%
Immunology and Microbiology
Antibody Affinity
7%
Blood Plasma
7%
Hemagglutination Inhibition
14%
Influenza
100%
Intravenous Immunoglobulin
100%
Solution and Solubility
7%